Compound
    Moderate Evidence

    Huperzine A

    Huperzia serrata extract

    TL;DR

    Huperzine A is a potent acetylcholinesterase inhibitor from club moss, dosed at 50-200 mcg. Effective but drug-like, with a long half-life and real side effects.

    Ideal For

    • Adults seeking short-term memory and learning support, used cyclically
    • People stacking with a choline source such as alpha-GPC
    • Those researching cholinergic approaches to cognitive decline, with medical input

    Avoid If

    • You take donepezil, rivastigmine or galantamine
    • You have bradycardia or a cardiac conduction disorder
    • You have asthma or COPD
    • You have epilepsy
    • You have peptic ulcer disease
    • You are pregnant or breastfeeding

    Frequently Asked Questions

    Overview

    Huperzine A is an alkaloid isolated from Chinese club moss (Huperzia serrata), used in traditional Chinese medicine and developed in China as a treatment for Alzheimer's disease, where it is available as a prescription drug. It is a reversible, highly selective inhibitor of acetylcholinesterase, the enzyme that clears acetylcholine from the synapse — the same mechanism as donepezil and rivastigmine.

    This is the key framing point for anyone considering it as a nootropic: huperzine A is not a gentle herbal cognitive enhancer, it is a pharmacologically potent enzyme inhibitor that happens to come from a plant. It is active at microgram doses, crosses the blood-brain barrier readily, and has a plasma half-life of around 10-14 hours with central effects lasting longer. Meta-analyses of Chinese trials in Alzheimer's disease report improvements in MMSE and activities of daily living, though methodological quality is variable and Western replication is limited.

    For healthy users, benefits on memory are less clear and the risk profile deserves respect. Continuous daily use leads to receptor downregulation, which is why cycling — five days on, two off, or three weeks on and one off — is the common practice. Cholinergic side effects including nausea, sweating, vivid dreams, muscle cramps and bradycardia are dose-dependent and not rare. It should never be combined with prescription cholinesterase inhibitors.

    How It Works

    • Reversible and selective inhibition of acetylcholinesterase, raising synaptic acetylcholine
    • Crosses the blood-brain barrier efficiently with high central bioavailability
    • NMDA receptor antagonism, offering some protection against glutamate excitotoxicity
    • Neuroprotective effects against beta-amyloid toxicity in preclinical models
    • Long half-life of 10-14 hours, so effects accumulate with daily dosing

    Quick Facts

    • Increases acetylcholine levels
    • Enhances memory formation
    • Neuroprotective properties
    • Improves learning capacity
    • Supports focus and clarity

    Health Concerns Addressed

    No linked health concerns yet.

    Supporting Research
    6 studies

    Huperzine A for Alzheimer's disease (Cochrane review)

    Score: 9/10
    2008
    systematic_review
    n=474

    Li J, Wu HM, Zhou RL +2 more

    There is currently insufficient evidence of the effects of huperzine A for Alzheimer's disease.

    View source

    A phase II trial of huperzine A in mild to moderate Alzheimer disease

    Score: 9/10
    2011
    rct
    n=210

    Rafii MS, Walsh S, Little JT +6 more

    The primary outcome, change in ADAS-Cog at week 16, did not differ from placebo.

    View source

    Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials

    Score: 8/10
    2013
    meta_analysis
    n=1823

    Yang G, Wang Y, Tian J +1 more

    Huperzine A improved MMSE and activities of daily living scores versus placebo, but all trials had unclear or high risk of bias.

    View source

    Efficacy and safety of the natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis

    Score: 7/10
    2009
    meta_analysis
    n=733

    Wang BS, Wang H, Wei ZH +3 more

    Huperzine A improved MMSE by roughly 2.8 points and ADL scores versus placebo.

    View source

    Huperzine A in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis

    Score: 7/10
    2014
    meta_analysis
    n=1400

    Xing SH, Zhu CX, Zhang R +1 more

    Huperzine A significantly improved MMSE and ADL scores in both Alzheimer's disease and vascular dementia.

    View source

    Huperzine A for mild cognitive impairment: a systematic review of randomised controlled trials

    Score: 8/10
    2012
    systematic_review
    0

    Yue J, Dong BR, Lin X +3 more

    No trials of adequate quality were identified for mild cognitive impairment.

    View source

    Safety Information

    Potential Side Effects

    Dose-dependent cholinergic effects: nausea, sweating, vivid dreams, insomnia if taken late, muscle twitching or cramps, increased salivation, diarrhoea and bradycardia. These are meaningfully more common than with typical herbal supplements and are the main reason to start low.

    Contraindications

    Never combine with prescription cholinesterase inhibitors — the effects are additive and potentially dangerous. Avoid with bradycardia, cardiac conduction abnormalities, asthma, COPD, epilepsy and peptic ulcer disease, all of which cholinergic activity can worsen.

    Drug Interactions

    • Donepezil, rivastigmine and galantamine — additive cholinesterase inhibition, do not combine
    • Beta blockers — additive bradycardia
    • Anticholinergic drugs — mutually antagonistic
    • Succinylcholine and other neuromuscular blockers — prolonged effect; tell your anaesthetist
    • Cholinergic drugs including bethanechol — additive effects

    Pregnancy & Breastfeeding

    Pregnancy: unsafe

    Breastfeeding: insufficient_data

    Dosage Guidelines

    Dosage Used in Studies

    50-200 mcg

    Best Time to Take

    Morning — evening dosing commonly causes vivid dreams and disrupted sleep

    Best Form

    Isolated or precisely standardised huperzine A, so the microgram dose is unambiguous

    Bioavailability

    Well absorbed orally. Crosses blood-brain barrier. Potent acetylcholinesterase inhibitor. Long half-life. Start with low dose. Cycle use recommended.

    Forms Compared

    Huperzine A 1% extract

    Isolated huperzine A

    Nootropic stacks

    Food & Timing

    With food to reduce nausea

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.